Co-Diagnostics

Aug 12, 2021

•

Jun 30, 2021

Co-Diagnostics Q2 2021 Earnings Report

Reported strong second quarter results, highlighted by revenue of $27.4 million, pre-tax income of $11.9 million and diluted EPS of $0.33.

Key Takeaways

Co-Diagnostics reported a strong second quarter with revenue of $27.4 million, pre-tax income of $11.9 million, and diluted EPS of $0.33. The company is focused on delivering high-quality diagnostic testing kits and is positioned for future growth with investments in talent and R&D.

Delivered strong quarterly results following record results in 2020.

Cultivated distributor relationships throughout the United States and abroad, resulting in record sales.

Focused on delivering high-quality diagnostic testing kits to customers worldwide amidst emerging COVID-19 variants.

Investments in talent and R&D continue to yield positive results, particularly with the Eikon point of care technology platform.